Which statement correctly distinguishes vaccine efficacy from vaccine effectiveness, and what determines the herd immunity threshold?

Study for the Immunity, Vaccines, and Cancer Test. Utilize flashcards and multiple-choice questions with detailed explanations. Prepare for excellence in your exam!

Multiple Choice

Which statement correctly distinguishes vaccine efficacy from vaccine effectiveness, and what determines the herd immunity threshold?

Explanation:
The key idea here is how a vaccine’s performance is described in different contexts and what sets the target for herd immunity. Vaccine efficacy measures how well the vaccine prevents disease under tightly controlled, ideal conditions in clinical trials. It reflects the biological protection the vaccine offers when everything goes as planned. Vaccine effectiveness, by contrast, captures how well the vaccine protects people in real-world settings where adherence, access, population diversity, and logistical factors vary. That distinction is exactly what the statement emphasizes: efficacy under ideal conditions and effectiveness in real-world settings. Herd immunity threshold is driven by how contagious the pathogen is, which is quantified by the basic reproduction number, R0. A higher R0 means more people need to be immune to stop transmission, so the target rises with R0. In the simplest terms, if the vaccine were perfectly effective and coverage could reach a theoretical level, the threshold is linked to 1 minus 1 over R0; with real-world vaccines that aren’t 100% effective, the required level of population immunity increases and depends on both R0 and how effective the vaccine is.

The key idea here is how a vaccine’s performance is described in different contexts and what sets the target for herd immunity. Vaccine efficacy measures how well the vaccine prevents disease under tightly controlled, ideal conditions in clinical trials. It reflects the biological protection the vaccine offers when everything goes as planned. Vaccine effectiveness, by contrast, captures how well the vaccine protects people in real-world settings where adherence, access, population diversity, and logistical factors vary. That distinction is exactly what the statement emphasizes: efficacy under ideal conditions and effectiveness in real-world settings.

Herd immunity threshold is driven by how contagious the pathogen is, which is quantified by the basic reproduction number, R0. A higher R0 means more people need to be immune to stop transmission, so the target rises with R0. In the simplest terms, if the vaccine were perfectly effective and coverage could reach a theoretical level, the threshold is linked to 1 minus 1 over R0; with real-world vaccines that aren’t 100% effective, the required level of population immunity increases and depends on both R0 and how effective the vaccine is.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy